The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Cost-Effectiveness of Screening for HIV in the Era of Highly Active Antiretroviral Therapy
Open accessAbstract
BACKGROUND: The costs, benefits, and cost-effectiveness of screening for human immunodeficiency virus (HIV) in health care settings during the era of highly active antiretroviral therapy (HAART) have not been determined. METHODS: We developed a Markov model of costs, quality of life, and survival associated with an HIV-screening program as compared with current practice. In both strategies, symptomatic patients were identified through symptom-based case finding. Identified patients started treatment when their CD4 count dropped to 350 cells per cubic millimeter. Disease progression was defined on the basis of CD4 levels and viral load. The likelihood of sexual transmission was based on viral load, knowledge of HIV status, and efficacy of counseling. RESULTS: Given a 1 percent prevalence of unidentified HIV infection, screening increased life expectancy by 5.48 days, or 4.70 quality-adjusted days, at an estimated cost of 194 dollars per screened patient, for a cost-effectiveness ratio of 15,078 dollars per quality-adjusted life-year. Screening cost less than 50,000 dollars per quality-adjusted life-year if the prevalence of unidentified HIV infection exceeded 0.05 percent. Excluding HIV transmission, the cost-effectiveness of screening was 41,736 dollars per quality-adjusted life-year. Screening every five years, as compared with a one-time screening program, cost 57,138 dollars per quality-adjusted life-year, but was more attractive in settings with a high incidence of infection. Our results were sensitive to the efficacy of behavior modification, the benefit of early identification and therapy, and the prevalence and incidence of HIV infection. CONCLUSIONS: The cost-effectiveness of routine HIV screening in health care settings, even in relatively low-prevalence populations, is similar to that of commonly accepted interventions, and such programs should be expanded.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_2-199806151-00003 · Cited by 5,209
Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1
Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., Meehan, M. O., Lutalo, T., & Gray, R. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421303 · Cited by 3,020
The social organization of sexuality: sexual practices in the United States
(1995) · Choice Reviews Online · doi:10.5860/choice.32-4802a · Cited by 2,890
Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma
Mellors, J. W., Rinaldo, C. R., Gupta, P., White, R. M., Todd, J. A., & Kingsley, L. A. (1996) · Science · doi:10.1126/science.272.5265.1167 · Cited by 2,660
Hammer, S. M., Squires, K. E., Hughes, M. D., Grimes, J. M., Demeter, L. M., Currier, J. S., Eron, J. J., Feinberg, J. E., Balfour, H. H., Deyton, L. R., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371101 · Cited by 2,640
Recommendations of the Panel on Cost-Effectiveness in Health and Medicine
Weinstein, M. C. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540150055031 · Cited by 2,455
Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection
Mellors, J. W., Munoz, A., Giorgi, J. V., Margolick, J. B., Tassoni, C. J., Gupta, P., Kingsley, L. A., Todd, J. A., Saah, A. J., Detels, R., et al. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-12-199706150-00003 · Cited by 2,067
Gulick, R. M., Mellors, J. W., Havlir, D., Eron, J. J., Gonzalez, C., McMahon, D., Richman, D. D., Valentine, F. T., Jonas, L., Meibohm, A., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371102 · Cited by 1,885
National Hospital Discharge Survey, 1988: Archival Version
United States Department of Health and Human Services. National Center for Health Statistics (1991) · ICPSR Data Holdings · doi:10.3886/icpsr09521 · Cited by 1,310
Carpenter, C. C. J., Cooper, D. A., Fischl, M. A., Gatell, J. M., Gazzard, B. G., Hammer, S. M., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., Montaner, J. S. G., et al. (2000) · JAMA · doi:10.1001/jama.283.3.381 · Cited by 1,012
Staszewski, S., Morales-Ramirez, J., Tashima, K. T., Rachlis, A., Skiest, D., Stanford, J., Stryker, R., Johnson, P., Labriola, D. F., Farina, D., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912163412501 · Cited by 993
Kamb, M. L., Fishbein, M., Douglas, Jr., Rhodes, F., Rogers, J., Bolan, G., Zenilman, J., Hoxworth, T., Malotte, C. K., Iatesta, M., et al. (1998) · JAMA · doi:10.1001/jama.280.13.1161 · Cited by 973
Quantitation of HIV-1 RNA in Plasma Predicts Outcome after Seroconversion
Mellors, J. W., Kingsley, L. A., Rinaldo, C. R., Todd, J. A., Hoo, B. S., Kokka, R. P., & Gupta, P. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-8-199504150-00003 · Cited by 917
Ledergerber, B., Egger, M., Opravil, M., Telenti, A., Hirschel, B., Battegay, M., Vernazza, P., Sudre, P., Flepp, M., Furrer, H., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01122-8 · Cited by 906
Lucas, G. M., Chaisson, R. E., & Moore, R. D. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-2-199907200-00002 · Cited by 843
The social organization of sexuality : sexual practices in the United States
Laumann, E. O. (1994) · Cited by 833
Montaner, J. S. G., Reiss, P., Cooper, D., Vella, S., Harris, M., Conway, B., Wainberg, M. A., Smith, D., Robinson, P., Hall, D., et al. (1998) · JAMA · doi:10.1001/jama.279.12.930 · Cited by 756
Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial
Durant, J., Clevenbergh, P. A., Halfon, P., Delgiudice, P., Porsin, S., Simonet, P., Montagne, N., Boucher, C. A., Schapiro, J., & Dellamonica, P. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12291-2 · Cited by 752
Treatment for Adult HIV Infection: 2004 Recommendations of the International AIDS Society-USA Panel
Yeni, P. G., Hammer, S. M., Hirsch, M. S., Saag, M. S., Schechter, M., Carpenter, C. C. J., Fischl, M. A., Gatell, J. M., Gazzard, B. G., Jacobsen, D. M., et al. (2004) · JAMA · doi:10.1001/jama.292.2.251 · Cited by 737
The Beaver Dam Health Outcomes study: Initial Catalog of Health-state Quality Factors
Fryback, D. G., Dasbach, E. J., Klein, R., Klein, B. E. K., Dorn, N., Peterson, K., & Martin, P. A. (1993) · Medical Decision Making · doi:10.1177/0272989x9301300202 · Cited by 733
Hogg, R. S. (2001) · JAMA · doi:10.1001/jama.286.20.2568 · Cited by 728
Changes in Plasma HIV-1 RNA and CD4+ Lymphocyte Counts and the Risk of Progression to AIDS
O'Brien, W. A., Hartigan, P. M., Martin, D., Esinhart, J., Hill, A., Benoit, S., Rubin, M., Simberkoff, M. S., & Hamilton, J. D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602153340703 · Cited by 720
A Longitudinal Study of Human Immunodeficiency Virus Transmission by Heterosexual Partners
De Vincenzi, I. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408113310601 · Cited by 657
Mankiw, N. G. (1983) · Cited by 609
Monforte, A. D., Lepri, A. C., Rezza, G., Pezzotti, P., Antinori, A., Phillips, A. N., Angarano, G., Colangeli, V., Luca, A. D., Ippolito, G., et al. (2000) · AIDS · doi:10.1097/00002030-200003310-00005 · Cited by 554
Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease
Cameron, D. W., Heath-Chiozzi, M., Danner, S., Cohen, C., Kravcik, S., Maurath, C., Sun, E., Henry, D., Rode, R., Potthoff, A., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)04161-5 · Cited by 536
The Care of HIV-Infected Adults in the United States
Bozzette, S. A., Berry, S. H., Duan, N., Frankel, M. R., Leibowitz, A. A., Lefkowitz, D., Emmons, C.-A., Senterfitt, J. W., Berk, M. L., Morton, S. C., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812243392606 · Cited by 508
The Cost Effectiveness of Combination Antiretroviral Therapy for HIV Disease
Freedberg, K. A., Losina, E., Weinstein, M. C., Paltiel, A. D., Cohen, C. J., Seage, G. R., Craven, D. E., Zhang, H., Kimmel, A. D., & Goldie, S. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441108 · Cited by 508
DiClemente, R. J. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530160023028 · Cited by 504
Baxter, J. D., Mayers, D. L., Wentworth, D. N., Neaton, J. D., Hoover, M. L., Winters, M. A., Mannheimer, S., Thompson, M., Abrams, D. I., Brizz, B., et al. (2000) · AIDS · doi:10.1097/00002030-200006160-00001 · Cited by 494
Katzenstein, D. A., Hammer, S. M., Hughes, M. D., Gundacker, H., Jackson, J. B., Fiscus, S., Rasheed, S., Elbeik, T., Reichman, R., Japour, A., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610103351502 · Cited by 477
HIV in the United States at the turn of the century: an epidemic in transition
(2001) · American Journal of Public Health · doi:10.2105/ajph.91.7.1060 · Cited by 471
National hospital discharge survey: 2004 annual summary with detailed diagnosis and procedure data.
Kozak, L. J., DeFrances, C. J., & Hall, M. J. (2006) · PubMed · Cited by 456
Palella, F. J., Deloria-Knoll, M., Chmiel, J. S., Moorman, A. C., Wood, K. C., Greenberg, A. E., Holmberg, S. D., & and the HIV Outpatient Study (HOPS) Investigators* (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-8-200304150-00007 · Cited by 443
Deeks, S. G., Hecht, F. M., Swanson, M., Elbeik, T., Loftus, R., Cohen, P. T., & Grant, R. M. (1999) · AIDS · doi:10.1097/00002030-199904160-00001 · Cited by 436
Fat distribution and metabolic changes in patients with HIV infection
Safrin, S., & Grunfeld, C. (1999) · AIDS · doi:10.1097/00002030-199912240-00002 · Cited by 359
Padian, N. S., Shiboski, S. C., Glass, S. O., & Vittinghoff, E. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009276 · Cited by 334
Havlir, D. V., Marschner, I. C., Hirsch, M. S., Collier, A. C., Tebas, P., Bassett, R. L., Ioannidis, J. P. A., Holohan, M. K., Leavitt, R., Boone, G., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810293391801 · Cited by 307
The NIMH Multisite HIV Prevention Trial: Reducing HIV Sexual Risk Behavior
The National Institute of Mental Health (NIMH) Multisite HIV Prevention Trial Group* (1998) · Science · doi:10.1126/science.280.5371.1889 · Cited by 285
Hughes, M. D., Johnson, V. A., Hirsch, M. S., Bremer, J. W., Elbeik, T., Erice, A., Kuritzkes, D. R., Scott, W. A., Spector, S. A., Basgoz, N., et al. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-12-199706150-00001 · Cited by 280
Lemp, G. F. (1994) · JAMA · doi:10.1001/jama.272.6.449 · Cited by 276
Bozzette, S. A., Joyce, G., McCaffrey, D. F., Leibowitz, A. A., Morton, S. C., Berry, S. H., Rastegar, A., Timberlake, D., Shapiro, M. F., & Goldman, D. P. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441107 · Cited by 265
Raboud, J. M., Montaner, J. S. G., Conway, B., Rae, S., Reiss, P., Vella, S., Cooper, D., Lange, J., Harris, M., Wainberg, M. A., et al. (1998) · AIDS · doi:10.1097/00002030-199813000-00008 · Cited by 259
O'Brien, W. A., Hartigan, P. M., Daar, E. S., Simberkoff, M. S., & Hamilton, J. D. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-12-199706150-00002 · Cited by 259
Natural History of HIV-1 Cell-Free Viremia
Henrard, D. R. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530070052029 · Cited by 254
Marschner, I. C., Collier, A. C., Coombs, R. W., D'Aquila, R. T., DeGruttola, V., Fischl, M. A., Hammer, S. M., Hughes, M. D., Johnson, V. A., Katzenstein, D. A., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/513823 · Cited by 240
Paredes, R. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.8.1123 · Cited by 235
Recommendations of the Panel on Cost-effectiveness in Health and Medicine
Weinstein, M. C. (1996) · JAMA · doi:10.1001/jama.276.15.1253 · Cited by 235
Gulick, R. M., Mellors, J. W., Havlir, D., Eron, J. J., Gonzalez, C., McMahon, D., Jonas, L., Meibohm, A., Holder, D., Schleif, W. A., et al. (1998) · JAMA · doi:10.1001/jama.280.1.35 · Cited by 234
Zolopa, A. R., Shafer, R. W., Warford, A. L., Montoya, J. G., Hsu, P., Katzenstein, D. A., Merigan, T. C., & Efron, B. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-11-199912070-00003 · Cited by 225
Kempf, D. J., Rode, R. A., Xu, Y., Sun, E., Heath-Chiozzi, M. E., Valdes, J., Japour, A. J., Danner, S., Boucher, C., Molla, A., et al. (1998) · AIDS · doi:10.1097/00002030-199805000-00001 · Cited by 222
Vlahov, D., Graham, N., Hoover, D., Flynn, C., Bartlett, J. G., Margolick, J. B., Lyles, C. M., Nelson, K. E., Smith, D., Holmberg, S., et al. (1998) · JAMA · doi:10.1001/jama.279.1.35 · Cited by 215
3-Year Suppression of HIV Viremia with Indinavir, Zidovudine, and Lamivudine
Gulick, R. M., Mellors, J. W., Havlir, D., Eron, J. J., Meibohm, A., Condra, J. H., Valentine, F. T., McMahon, D., Gonzalez, C., Jonas, L., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-1-200007040-00007 · Cited by 204
Predictors of optimal virological response to potent antiretroviral therapy
Powderly, W. G., Saag, M. S., Chapman, S. K., Yu, G. W., Quart, B. D., & Clendeninn, N. J. (1999) · AIDS · doi:10.1097/00002030-199910010-00009 · Cited by 192
Ritonavir and saquinavir combination therapy for the treatment of HIV infection
Cameron, W., Japour, A. J., Xu, Y., Hsu, A., Mellors, J., Farthing, C., Cohen, C., Poretz, D., Markowitz, M., Follansbee, S., et al. (1999) · AIDS · doi:10.1097/00002030-199902040-00009 · Cited by 191
Notermans, D. W., Jurriaans, S., de Wolf, F., Foudraine, N. A., de Jong, J. J., Cavert, W., Schuwirth, C. M., Kauffmann, R. H., Meenhorst, P. L., McDade, H., et al. (1998) · AIDS · doi:10.1097/00002030-199802000-00006 · Cited by 185
Scope of the AIDS Epidemic in the United States
Rosenberg, P. S. (1995) · Science · doi:10.1126/science.270.5240.1372 · Cited by 178
Coombs, R. W., Welles, S. L., Hooper, C. J., Reichelderfer, P. A., D’Aquila, R. T., Japour, A. J., Kuritzkes, D. R., Richman, D. D., Kwok, S., Todd, J., et al. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.4.704 · Cited by 172
Sullivan, P. S., Lansky, A., & Drake, A. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200404150-00009 · Cited by 170
Le Moing, V., Chêne, G., Carrieri, M. P., Alioum, A., Brun-Vézinet, F., Piroth, L., Cassuto, J. P., Moatti, J.-P., Raffi, F., & Leport, C. (2002) · AIDS · doi:10.1097/00002030-200201040-00004 · Cited by 166
de Wolf, F., Spijkerman, I., Schellekens, P. T., Langendam, M., Kuiken, C., Bakker, M., Roos, M., Coutinho, R., Miedema, F., & Goudsmit, J. (1997) · AIDS · doi:10.1097/00002030-199715000-00003 · Cited by 164
A Meta-Analysis of Utility Estimates for HIV/AIDS
Tengs, T. O., & Lin, T. H. (2002) · Medical Decision Making · doi:10.1177/0272989x02238300 · Cited by 160
Tebas, P., Patick, A. K., Kane, E. M., Klebert, M. K., Simpson, J. H., Erice, A., Powderly, W. G., & Henry, K. (1999) · AIDS · doi:10.1097/00002030-199902040-00002 · Cited by 158
Kelen, G. D., Shahan, J. B., & Quinn, T. C. (1999) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(99)70387-2 · Cited by 157
On-site, rapid HIV testing with same-day results and counseling
Kassler, W. J., Dillon, B. A., Haley, C., Jones, W. K., & Goldman, A. (1997) · AIDS · doi:10.1097/00002030-199708000-00014 · Cited by 155
Monforte, A. D., Testa, L., Adorni, F., Chiesa, E., Bini, T., Moscatelli, G., Abeli, C., Rusconi, S., Sollima, S., Balotta, C., et al. (1998) · AIDS · doi:10.1097/00002030-199813000-00010 · Cited by 137
Change in clinical status, health status, and health utility outcomes in HIV-infected patients.
Revicki, D. A., Wu, A. W., & Murray, M. I. (1995) · PubMed · Cited by 136
Heterosexual Transmission of HIV in Haiti
Deschamps, M.-M., Pape, J. W., Hafner, A., & Johnson, W. D. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-4-199608150-00011 · Cited by 136
Musicco, M., Lazzarin, A., Nicolosi, A., Gasparini, M., Costigliola, P., Arici, C., & Saracco, A. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.17.1971 · Cited by 133
Buchbinder, S., Douglas, J. M., McKirnan, D. J., Judson, F. N., Katz, M. H., & MacQueen, K. M. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.5.954 · Cited by 128
Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patients
Casado, J. L., Pérez-Elı́as, M. J., Antela, A., Sabido, R., Martí-Belda, P., Dronda, F., Blázquez, J., & Quereda, C. (1998) · AIDS · doi:10.1097/00002030-199811000-00005 · Cited by 124
The Will To Live among HIV-Infected Patients
Tsevat, J., Sherman, S. N., McElwee, J. A., Mandell, K. L., Simbartl, L. A., Sonnenberg, F. A., & Fowler, F. J. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-3-199908030-00006 · Cited by 121
Health Values of Patients Infected with Human Immunodeficiency Virus
Tsevat, J., SOLZAN, J. G., Kuntz, K. M., Ragland, J., Currier, J. S., Sell, R. L., & Weinstein, M. C. (1996) · Medical Care · doi:10.1097/00005650-199601000-00004 · Cited by 121
Opravil, M., Ledergerber, B., Furrer, H., Hirschel, B. J., Imhof, A., Gallant, S., Wagels, T., Bernasconi, E., Meienberg, F., Rickenbach, M., et al. (2002) · AIDS · doi:10.1097/00002030-200207050-00009 · Cited by 111
Cozzi‐Lepri, A., Phillips, A. N., Monforte, A. D., Castelli, F., Antinori, A., Luca, A. D., Pezzotti, P., Alberici, F., Cargnel, A., Grima, P., et al. (2001) · AIDS · doi:10.1097/00002030-200105250-00006 · Cited by 110
Cost-utility analyses of clinical preventive services
Stone, P. W., Teutsch, S. M., Chapman, R. H., Bell, C. M., Goldie, S. J., & Neumann, P. J. (2000) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(00)00151-3 · Cited by 108
HIV-1 RNA levels and the development of clinical disease
Phillips, A. N., Eron, J. J., Bartlett, J. A., Rubin, M., Johnson, J., Price, S., Self, P., & Hill, A. M. (1996) · AIDS · doi:10.1097/00002030-199607000-00009 · Cited by 88
Failure To Return for HIV Posttest Counseling in an STD Clinic Population
Hightow‐Weidman, L., Miller, W. C., Leone, P. A., Wohl, D. A., Smurzynski, M., & Kaplan, A. H. (2003) · AIDS Education and Prevention · doi:10.1521/aeap.15.4.282.23826 · Cited by 85
Valdez, H., Lederman, M. M., Woolley, I. J., Walker, C. J., Vernon, L. T., Hise, A. G., & Gripshover, B. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.15.1771 · Cited by 85
Samuel, M. C., Hessol, N. A., SHIBOSKI, S. C., Engel, R. R., Speed, T. P., & Winkelstein, W. (1993) · PubMed · Cited by 82
Operskalski, E. A., Stram, D. O., Busch, M. P., Huang, W., Harris, M., Dietrich, S. L., Schiff, E. R., Donegan, E. A., Mosley, J. W., & for the Transfusion Safety Study Group (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009331 · Cited by 82
Chêne, G., Binquet, C., Moreau, J., Neau, D., Pellegrin, I., Malvy, D. J.-M., Ceccaldi, J., Lacoste, D., & Dabis, F. (1998) · AIDS · doi:10.1097/00002030-199817000-00013 · Cited by 74
Costs of HIV+/AIDS at CD4+ Counts Disease Stages Based on Treatment Protocols
Gable, C. B., Tierce, J. C., Simison, D., Ward, D., & Motte, K. (1996) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199608010-00013 · Cited by 70
Erb, P. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.8.1134 · Cited by 70
Maher, K. J., Klimas, N. G., Fletcher, M. A., Cohen, V., Maggio, C. M., Triplett, J. W., Valenzuela, R., & Dickinson, G. (1999) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-199912010-00006 · Cited by 68
Anastos, K., Barrón, Y., Miotti, P., Weiser, B., Young, M., Hessol, N., Greenblatt, R. M., Cohen, M., Augenbraun, M., Levine, A., et al. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.17.1973 · Cited by 64
Michael, R. T., Wadsworth, J., Feinleib, J. A., et al. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.5.749 · Cited by 62
Keiser, P. H., Kvanli, M. B., Turner, D., et al. (1999) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199901010-00004 · Cited by 60
Male homosexual transmission of HIV-1
Cáceres, C. F., & van Griensven, G. J. P. (1994) · AIDS · doi:10.1097/00002030-199408000-00004 · Cited by 58
Reijers, M. H. E., Weigel, H. M., Hart, A. A. M., ten Kate, R. W., Mulder, J. W., Reiss, P., Schuitemaker, H., Hoetelmans, R. M. W., Weverling, G. J., & Lange, J. M. A. (2000) · AIDS · doi:10.1097/00002030-200001070-00007 · Cited by 58
Shulman, N. S., Zolopa, A. R., Passaro, D. J., Murlidharan, U., Israelski, D. M., Brosgart, C. L., Miller, M. D., Doren, S. V., Shafer, R. W., & Katzenstein, D. A. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200003010-00002 · Cited by 57
Staszewski, S., DeMasi, R. A., Hill, A. M., & Dawson, D. (1998) · AIDS · doi:10.1097/00002030-199815000-00010 · Cited by 57
Turner, B. J. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420140022004 · Cited by 54
Hall, C. S., Raines, C. P., Barnett, S. H., Moore, R. D., & Gallant, J. E. (1999) · AIDS · doi:10.1097/00002030-199907090-00009 · Cited by 52
Who should be screened for HIV infection? A cost-effectiveness analysis
McCarthy, B. D., Wong, J. B., Muñoz, A., & Sonnenberg, F. A. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.9.1107 · Cited by 49
Drusano, G. L., D’Argenio, D. Z., Symonds, W., Bilello, P., McDowell, J. A., Sadler, B., Bye, A., & Bilello, J. A. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2153 · Cited by 47
When to Initiate Highly Active Antiretroviral Therapy: A Cohort Approach
Ahdieh-Grant, L. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg036 · Cited by 45
Analysis of HIV-1 clinical trials: statistical magic?
(1999) · The Lancet · doi:10.1016/s0140-6736(98)10391-4 · Cited by 43
Phillips, K. A., & Fernyak, S. E. (2000) · AIDS · doi:10.1097/00002030-200009290-00013 · Cited by 42
Management of Antiretroviral Therapy for HIV Infection: Modelling when to Change Therapy
D'Amato, R. M., D’Aquila, R. T., & Wein, L. M. (1998) · Antiviral Therapy · doi:10.1177/135965359800300302 · Cited by 35
Analytic Tools for Public Health Decision Making
Owens, D. K. (2002) · Medical Decision Making · doi:10.1177/027298902237969 · Cited by 26
Self-citationMontaner, J. S. G., DeMasi, R. A., & Hill, A. M. (1998) · AIDS · doi:10.1097/00002030-199805000-00003 · Cited by 25
Evaluation of a Hospital Admission HIV Antibody Voluntary Screening Program
Harris, R. L., Boisaubin, E. V., Salyer, P. D., & Semands, D. F. (1990) · Infection Control and Hospital Epidemiology · doi:10.1086/646112 · Cited by 24
Turner, B. J. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.14.1561 · Cited by 16
Raboud, J., Rae, S. L., Vella, S., Harrigan, P. R., Bucciardini, R., Fragola, V., Ricciardulli, D., & Montaner, J. S. G. (1999) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-199911010-00007 · Cited by 15
Cited by
(2006) · PsycEXTRA Dataset · doi:10.1037/e545592006-001 · Cited by 2,958
State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3
Siebert, U., Alagoz, O., Bayoumi, A. M., Jahn, B., Owens, D. K., Cohen, D. J., & Kuntz, K. M. (2012) · Value in Health · doi:10.1016/j.jval.2012.06.014 · Cited by 588
Self-citationOperations Research in Healthcare: a survey
Rais, A., & Viana, A. (2011) · International Transactions in Operational Research · doi:10.1111/j.1475-3995.2010.00767.x · Cited by 393
Girardi, E., Sabin, C. A., & Monforte, A. D. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000286597.57066.2b · Cited by 350
State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force–3
Siebert, U., Alagoz, O., Bayoumi, A. M., Jahn, B., Owens, D. K., Cohen, D. J., & Kuntz, K. M. (2012) · Medical Decision Making · doi:10.1177/0272989x12455463 · Cited by 348
Self-citation
Metadata
- Authors
- Sanders, G. D., Bayoumi, A. M., Sundaram, V., Bilir, S. P., Neukermans, C. P., Rydzak, C. E., Douglass, L. R., Lazzeroni, L. C., Holodniy, M., & Owens, D. K.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-02-10
- Volume
- 352
- Issue
- 6
- Pages
- 570-585
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2151969385
- Cited by
- 603
- References
- 105
- FWCI
- 29.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.